“…Such an issue is closely related to the improvement of the cellular uptake of antisense oligonucleotides by lipophilic modification. − According to this therapeutic strategy, short single-stranded DNA (ss-DNA) first bind to cellular membrane because of their hydrophobic moiety; then, after internalization, they hybridize to the targeted mRNA by sequence recognition and consequently prevent the translation of the associated protein. Oligonucleotides have been conjugated to numerous small lipophilic molecules including the widely used cholesterol, ,− alkyl chain, , di- o -alkyl- rac -glycerol, , fullerene, and adamantane . Biological effects such as inhibition of viral protein expression by lipid-conjugates could be observed on cell cultures, but the mechanisms ruling drug action are still unclear. , Indeed, cholesterol-DNA was found to bind to low-density lipoproteins receptors, allowing an alternative internalization route to passive membrane anchoring followed by pinocytosis .…”